GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Trade Payables History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Trade Payables | ₹570 Cr | ₹708 Cr | ₹625 Cr | ₹428 Cr | ₹579 Cr |
What is the latest Trade Payables ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Trade Payables |
|---|---|
| Mar2026 | ₹570 Cr |
| Mar2025 | ₹708 Cr |
| Mar2024 | ₹625 Cr |
| Mar2023 | ₹428 Cr |
| Mar2022 | ₹579 Cr |
How is Trade Payables of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2026 | ₹570 Cr | -19.49 | |
| Mar2025 | ₹708 Cr | 13.25 | |
| Mar2024 | ₹625 Cr | 46.20 | |
| Mar2023 | ₹428 Cr | -26.16 | |
| Mar2022 | ₹579 Cr | - | |
Compare Trade Payables of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹41,257.4 Cr | 1.5% | 12% | -25.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 1.5% |
12% |
-25.9% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses